Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Colorectal Dis ; 19(9): O329-O338, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28733982

RESUMO

AIM: This study aims to describe the nature, incidence, severity and outcomes of in-hospital postoperative complications (POCs) in older patients undergoing elective surgery for colorectal cancer. METHOD: Patients ≥ 70 years old were identified from a prospectively collected database (2009-2015) focusing on the implementation of geriatric screening and assessment in patients with cancer. Medical and surgical POCs were retrieved retrospectively from the medical records, and the severity of the POCs was graded by the Clavien-Dindo (CD) grading system. The following outcomes were analysed comparing patients with and without CD ≥ 2 and CD ≥ 3 POCs: length of stay (LOS), transfer to the intensive care unit, 30-day readmission rates, 30-day and 1-year mortality. RESULTS: In the 190 patients included, medical POCs (40.5%) were more frequent than surgical POCs (17.9%), and 37.9% experienced CD ≥ 2 POCs. The most common medical POCs were infections (26.8%), transient confusion or altered mental function (12.1%), cardiac arrhythmia (4.7%), and ileus/gastroparesis/prolonged recovery of transit (4.7%). The most common surgical POCs were surgical site infections (12.1%), wound dehiscence/bleeding (4.7%), anastomotic leak (3.7%) and surgical site bleeding (3.7%). The reoperation rate was 7.9%. CD ≥ 2 POCs led to 11 intensive care unit admissions and increased median postoperative LOS by 114% (P < 0.0001 for both), but did not significantly alter 30-day readmission and 30-day and 1-year mortality rates. CD ≥ 3 POCs increased LOS by 162% (P < 0.0001) and showed an increased 1-year mortality (P = 0.07). CONCLUSION: This study shows that in-hospital medical and surgical complications after surgery for colorectal cancer in patients ≥ 70 years old are frequent and that complications lead to less favourable outcomes.


Assuntos
Fatores Etários , Neoplasias Colorretais/cirurgia , Procedimentos Cirúrgicos do Sistema Digestório/efeitos adversos , Procedimentos Cirúrgicos Eletivos/efeitos adversos , Complicações Pós-Operatórias/etiologia , Idoso , Idoso de 80 Anos ou mais , Bases de Dados Factuais , Procedimentos Cirúrgicos do Sistema Digestório/métodos , Procedimentos Cirúrgicos Eletivos/métodos , Feminino , Avaliação Geriátrica , Hospitalização/estatística & dados numéricos , Humanos , Unidades de Terapia Intensiva/estatística & dados numéricos , Masculino , Complicações Pós-Operatórias/mortalidade , Estudos Prospectivos , Reoperação/estatística & dados numéricos , Estudos Retrospectivos
2.
Acta Gastroenterol Belg ; 84(2): 383-384, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34217195

Assuntos
Dor Abdominal , Idoso , Humanos
3.
Acta Clin Belg ; 68(2): 113-5, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23967719

RESUMO

A 83-year-old woman was admitted to hospital with chest pain, fever, dry cough and palpitations. Chest X-ray revealed a pleural effusion, assumed to be caused by cardiac failure and respiratory infection. Despite treatment with antibiotics and diuretics, the pleural effusion increased on chest X-ray and there were signs of pleural and pericardial effusion on computed tomography (CT) scan. Treatment with non-steroidal anti-inflammatory drugs (NSAIDs) was not successful. Meanwhile patients' long-term use of ergotamine for migraine was revealed, which is associated with pleuropulmonary and cardiac fibrotic reactions. Tentative treatment with colchicine was successful, with complete resolution of pleural fluid, fever, cough and inflammatory parameters. This case highlights the importance of establishing an ergot alkaloid use registry in unexplained pleuropericardial effusions and supports the use of colchicine as a potential therapeutic approach.


Assuntos
Colchicina/uso terapêutico , Ergotamina/efeitos adversos , Derrame Pericárdico/induzido quimicamente , Derrame Pericárdico/tratamento farmacológico , Derrame Pleural/induzido quimicamente , Derrame Pleural/tratamento farmacológico , Moduladores de Tubulina/uso terapêutico , Vasoconstritores/efeitos adversos , Idoso de 80 Anos ou mais , Diagnóstico Diferencial , Feminino , Humanos , Transtornos de Enxaqueca/tratamento farmacológico , Derrame Pericárdico/diagnóstico , Derrame Pleural/diagnóstico
4.
Eur J Paediatr Neurol ; 16(1): 20-8, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21945796

RESUMO

AIM: To distinguish the effects of different physiotherapeutic programs in a post BTX-A regime for children with Cerebral Palsy (CP). DESIGN: Retrospective, controlled intervention study. PARTICIPANTS AND INTERVENTIONS: A group of 38 children (X¯ = 7y7m, GMFCS I-III, 27 bilateral, 11 unilateral CP) receiving an individually defined Neurodevelopment Treatment (NDT) program, was matched and compared to a group of children with the same age, GMFCS and diagnosis, receiving more conventional physiotherapy treatment. All patients received selective tone-reduction by means of multilevel BTX-A injections and adequate follow-up treatment, including physiotherapy. OUTCOME MEASURES: Three-dimensional gait analyses and clinical examination was performed pre and two months post-injection. Treatment success was defined using the Goal Attainment Scale (GAS). RESULTS: Both groups' mean converted GAS scores were above 50. The average converted GAS score was higher in the group of children receiving NDT than in the group receiving conventional physiotherapy (p < 0.05). In the NDT group, overall treatment success was achieved in 76% of the goals, compared to 67% of the goals defined for the conventional physiotherapy group. Especially for the goals based on gait analyses (p < 0.05) and in the group of children with bilateral CP (p < 0.05), treatment success was higher in the NDT group. CONCLUSION: In a post-BTX-A regime, the short-term effects of an NDT approach are more pronouncedthan these from a conventional physiotherapy approach.


Assuntos
Toxinas Botulínicas Tipo A/administração & dosagem , Paralisia Cerebral/terapia , Terapia Combinada/métodos , Espasticidade Muscular/terapia , Fármacos Neuromusculares/administração & dosagem , Modalidades de Fisioterapia , Adolescente , Toxinas Botulínicas Tipo A/efeitos adversos , Paralisia Cerebral/tratamento farmacológico , Paralisia Cerebral/fisiopatologia , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Espasticidade Muscular/tratamento farmacológico , Espasticidade Muscular/fisiopatologia , Fármacos Neuromusculares/efeitos adversos , Estudos Retrospectivos , Método Simples-Cego , Resultado do Tratamento
5.
Acta Otorhinolaryngol Belg ; 55(2): 119-27, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11441470

RESUMO

There is little debate about the primacy of surgery in the management of symptomatic or complicated primary hyperparathyroidism. Rather, the question has been what to do about the many patients with nonclassical disease. Recent prospective data have confirmed that patients with asymptomatic primary hyperparathyroidism who are not surgical candidates for parathyroidectomy appear to do well when they are managed conservatively. On average, these patients remain stable, with little progression to the more serious manifestations of hyperparathyroidism over 10 years. It would seem, therefore, that the overall population of older patients with mild asymptomatic primary hyperparathyroidism can be safely followed without intervention. A certain proportion of cases do progress, however, so surveillance is necessary. Individual patients can have worsening hypercalcemia or hypercalciuria, and in a small percentage of patients, bone density may decrease over time. In most patients, deferral of surgery is not a one-time decision, but rather one that is reviewed and reconsidered in conjunction with meticulous monitoring.


Assuntos
Hiperparatireoidismo , Paratireoidectomia/métodos , Densidade Óssea , Cálcio/sangue , Cálcio/urina , Creatinina/urina , Feminino , Seguimentos , Humanos , Hipercalcemia/sangue , Hipercalcemia/diagnóstico , Hiperparatireoidismo/complicações , Hiperparatireoidismo/diagnóstico , Hiperparatireoidismo/fisiopatologia , Hiperparatireoidismo/cirurgia , Masculino , Nefrocalcinose/diagnóstico , Nefrocalcinose/epidemiologia , Nefrocalcinose/etiologia , Osteoporose/diagnóstico , Osteoporose/etiologia , Hormônio Paratireóideo/sangue , Complicações Pós-Operatórias , Cuidados Pré-Operatórios , Fatores de Tempo , Vitamina D/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA